Swissmedic Switzerland Medical Device Registration

Medical devices and IVDs placed on the Swiss market fall under the Medical Devices Ordinance (MedDO) and the In Vitro Diagnostic Medical Devices Ordinance (IvDO), overseen by Swissmedic. Swiss access combines recognized conformity evidence with local representation, importer checks, product information, registration and post-market duties. An EU registration does not complete those Swiss steps.

This guide covers the standard commercial route. Custom-made devices, in-house devices, clinical investigations and other special cases need a separate assessment of the applicable notification or authorization provisions. Registration in swissdamed is a traceability obligation; it is not a substitute for demonstrating conformity.

Switzerland medical device and IVD classification

Medical devices follow Classes I, IIa, IIb and III, with additional conformity-assessment involvement for sterile, measuring and reusable surgical Class I devices. IVDs follow Classes A, B, C and D; sterile Class A devices also require attention to the sterile aspects. Determine the intended purpose and classification rule before setting the evidence plan.

For a portfolio also targeting Europe, our EU MDR classification guide and IVDR services explain the corresponding evidence work. Keep the Swiss supply-chain requirements as a separate launch checklist.

Swiss medical device regulatory pathways

For the usual CE conformity route, prepare the applicable EU Declaration of Conformity and notified-body certificates where the classification requires them. Check the device scope, intended use, certificate status and any applicable legacy-device transition against the Swiss provisions. A CE logo or an ISO 13485 certificate alone is not the complete evidence package.

The conformity assessment and remediation work usually determine the launch schedule. Plan separately for preparing evidence, notified-body review where needed, local agreements, translations and database completion. A consultant's planning estimate is not a guaranteed Swissmedic approval clock.

Who needs a CH-REP, and what about Liechtenstein?

Manufacturers established outside Switzerland and Liechtenstein generally need an authorized representative for the Swiss market. An EU or UK representative does not automatically fulfill this role. Switzerland and Liechtenstein share a common market under the customs treaty when devices are placed under MedDO or IvDO; eligible Liechtenstein operators may act in the relevant local roles, and a Liechtenstein manufacturer does not need a separate Swiss representative solely because it is outside Switzerland.

Record the covered device groups, responsibilities, document access and communication procedures in the written mandate. The CH-REP checks the relevant conformity documentation, cooperates with Swissmedic and performs its defined registration and safety duties. The manufacturer retains its own obligations for product conformity and lifecycle surveillance. Set out how both parties will handle incidents, field safety corrective actions and requests for technical documentation.

Check the required placement of the representative's name and address for the device category. Swissmedic's CH-REP guidance explains identification and use of the CH-REP symbol; a postal box, email address or phone number alone does not provide the required contact address.

Who obtains a CHRN?

A CHRN identifies an eligible economic operator and its registered role. Manufacturers, authorized representatives, importers and persons assembling systems or procedure packs in the Switzerland/Liechtenstein common market must assess their actor obligations. Current CHRN instructions require applicable registration before first placing a device on the Swiss market.

A manufacturer outside that common market does not receive the representative's CHRN as its own manufacturer number. The CH-REP registers its own actor role and records its manufacturer mandates. Keep that distinction clear when reconciling company information, mandates and device records. EU SRNs and Swiss CHRNs serve different registration systems.

An importer is the local operator first placing a device from abroad on the Swiss market. This role follows the actual supply chain; it is separate from being appointed as CH-REP, even when one company performs both functions. Confirm the importer identification, conformity checks, traceability records and escalation process. In swissdamed, importers link their own CHRN-IM to the relevant registered devices rather than creating the manufacturer's device registration.

What are the swissdamed deadlines in 2026?

Actor registration was already required before the platform migration: Swissmedic dates the registration system to 26 November 2021, while the swissdamed Actors module became available in August 2024. Platform availability did not create the original duty.

Device registration became mandatory on 1 July 2026, with a general completion transition to 31 December 2026. This includes relevant portfolios with further sales units first placed after the obligation began. Serious-incident, FSCA or trend-reporting cases can require immediate registration once the necessary information is known. The official database FAQ also sets out exceptions, including special Master UDI-DI dates and handling for legacy optical devices. Check those cases before assigning one deadline to every product.

For certain high-risk devices, EUDAMED certificate-confirmation dependencies can affect data export. Follow the live special-case notice on Swissmedic's registration page when scheduling these uploads.

Can EUDAMED data be reused?

Yes, compatible EUDAMED GET DEVICE or POST DEVICE XML files can be uploaded into swissdamed. There is no automatic synchronization between the databases. Registration methods include the online editor, XML upload and a machine-to-machine REST API using JSON. Choose a method suited to the portfolio and available technical expertise, then verify identifiers, mandate ownership, market status and accepted records after submission.

What languages must labels and instructions use?

The general rule is product information in German, French and Italian. Choosing only the language of the sales canton does not satisfy that general rule. MedDO Article 16 and IvDO Article 15 provide conditional exceptions for eligible products and users, including certain professional-use circumstances. Document the applicable conditions and safety assessment before relying on fewer languages or English. Do not apply a professional-use exception automatically to consumer or self-test devices.

What documentation should manufacturers prepare?

• Intended purpose, classification rationale and applicable conformity route.
• Technical documentation, risk management, verification and validation evidence, with clinical or performance evaluation as applicable.
• Declaration of Conformity and notified-body certificates where required; verify product coverage and any transition conditions.
• An appropriate quality management system, with ISO 13485 evidence where relevant to the conformity route.
• The local representation mandate, applicable actor registrations and importer arrangements.
• Product information meeting Swiss language and economic-operator identification requirements.
• Device registration records, change owners and a documented surveillance and safety-reporting process.

Swissmedic does not generally require a separate Swiss Declaration of Conformity or the addition of a CHRN to the conformity certificate. Keep documentary requirements distinct from the separate labeling and database duties.

Certificate maintenance, registration fees and launch checks

Review conformity at the time each individual unit is first placed on the market. Certificate expiry or withdrawal does not create a blanket permission to place remaining manufacturer warehouse stock. Conversely, distinguish those units from units already lawfully placed, whose continued supply or use requires its own assessment. Maintain certificates, registrations and safety information throughout the relevant lifecycle.

Swissmedic calculates device-registration fees per manufacturer or system/procedure-pack assembler: CHF 200 for the first device and CHF 20 for each additional device, capped at CHF 10,000 in the annual calculation. Each device is charged once in its initial registration year; routine data updates are free. The initial assessment uses relevant records at 31 December 2026. Consult the current fee rules for market-status exclusions and invoicing through the CH-REP. These regulator charges are separate from commercial representation or consulting fees.

Before launch, reconcile the device list against the mandate, conformity documents, label versions, actor roles and accepted database records. Assign an owner for each outstanding action and for ongoing changes. This makes the market-access plan usable by regulatory, quality and distribution teams rather than leaving registration as a standalone data-entry task.